Thrombosis risk stratification: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Thrombosis}} | {{Thrombosis}} | ||
| Line 37: | Line 38: | ||
**Hypoplasminogenemia | **Hypoplasminogenemia | ||
**Familial homocysteinemia | **Familial homocysteinemia | ||
==References== | |||
{{ | {{reflist|2}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
| Line 45: | Line 45: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Revision as of 14:34, 25 September 2012
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis risk stratification On the Web |
|
Risk calculators and risk factors for Thrombosis risk stratification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
Risk factors
- Medical
- Familial
- Antithrombin III deficiency
- Protein C deficiency/Protein S deficiency
- APC resistance (Factor V Leiden)
- Dysfibrogenemia
- Hypoplasminogenemia
- Familial homocysteinemia